Private Advisor Group’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.7K Buy
24,737
+441
+2% +$789 ﹤0.01% 2602
2025
Q4
$45.4K Sell
24,296
-4,323
-15% -$8.31K ﹤0.01% 2524
2025
Q3
$36.6K Sell
28,619
-1,150
-4% -$1.56K ﹤0.01% 2468
2025
Q2
$36.9K Buy
29,769
+6,386
+27% +$7.38K ﹤0.01% 2366
2025
Q1
$27.6K Sell
23,383
-2,625
-10% -$4.03K ﹤0.01% 2261
2024
Q4
$47.6K Sell
26,008
-1,853
-7% -$3.62K ﹤0.01% 2215
2024
Q3
$47.4K Buy
27,861
+143
+0.5% +$235 ﹤0.01% 2353
2024
Q2
$38K Buy
27,718
+2,385
+9% +$4.82K ﹤0.01% 2283
2024
Q1
$95K Buy
25,333
+5,942
+31% +$34.8K ﹤0.01% 2204
2023
Q4
$190K Sell
19,391
-349
-2% -$2.85K ﹤0.01% 2052
2023
Q3
$165K Buy
19,740
+2,027
+11% +$23.2K ﹤0.01% 1912
2023
Q2
$236K Buy
17,713
+4,402
+33% +$53.5K ﹤0.01% 1770
2023
Q1
$154K Buy
13,311
+500
+4% +$4.97K ﹤0.01% 1826
2022
Q4
$105 Sell
12,811
-900
-7% -$7.75K ﹤0.01% 1578
2022
Q3
$80K Sell
13,711
-1,458
-10% -$8.37K ﹤0.01% 1801
2022
Q2
$67K Sell
15,169
-4,377
-22% -$26.6K ﹤0.01% 1990
2022
Q1
$178K Buy
19,546
+59
+0.3% +$679 ﹤0.01% 1918
2021
Q4
$399K Buy
19,487
+3,300
+20% +$79.6K ﹤0.01% 1577
2021
Q3
$414K Sell
16,187
-400
-2% -$11.9K ﹤0.01% 1596
2021
Q2
$580K Sell
16,587
-851
-5% -$24.8K 0.01% 1319
2021
Q1
$581K Buy
17,438
+2,552
+17% +$89.3K 0.01% 1230
2020
Q4
$386K Buy
14,886
+566
+4% +$9.62K ﹤0.01% 1346
2020
Q3
$141K Buy
14,320
+7,755
+118% +$44.6K ﹤0.01% 1457
2020
Q2
$23K Buy
+6,565
New +$22.4K ﹤0.01% 2502
2019
Q4
Sell
-10,000
Closed -$52K 1713
2019
Q3
$52K Buy
+10,000
New +$55.9K ﹤0.01% 1604

Other funds holding PACB